ATE433491T1 - Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potential - Google Patents
Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potentialInfo
- Publication number
- ATE433491T1 ATE433491T1 AT02722030T AT02722030T ATE433491T1 AT E433491 T1 ATE433491 T1 AT E433491T1 AT 02722030 T AT02722030 T AT 02722030T AT 02722030 T AT02722030 T AT 02722030T AT E433491 T1 ATE433491 T1 AT E433491T1
- Authority
- AT
- Austria
- Prior art keywords
- chimeric proteins
- immunogenic potential
- oligomeric complexes
- enhanced immunogenic
- complexes
- Prior art date
Links
- 102000037865 fusion proteins Human genes 0.000 title abstract 3
- 108020001507 fusion proteins Proteins 0.000 title abstract 3
- 230000002163 immunogen Effects 0.000 title 1
- 102000007474 Multiprotein Complexes Human genes 0.000 abstract 1
- 108010085220 Multiprotein Complexes Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01200193 | 2001-01-18 | ||
| PCT/EP2002/000628 WO2002074795A2 (en) | 2001-01-18 | 2002-01-18 | Oligomeric complexes of chimeric proteins with enhanced immunogenic potential |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE433491T1 true ATE433491T1 (de) | 2009-06-15 |
Family
ID=8179773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02722030T ATE433491T1 (de) | 2001-01-18 | 2002-01-18 | Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potential |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7449188B2 (de) |
| EP (1) | EP1362109B1 (de) |
| AT (1) | ATE433491T1 (de) |
| AU (1) | AU2002252978B9 (de) |
| CA (1) | CA2435000C (de) |
| DE (1) | DE60232577D1 (de) |
| DK (1) | DK1362109T3 (de) |
| ES (1) | ES2327719T3 (de) |
| WO (1) | WO2002074795A2 (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101455222B1 (ko) | 2002-12-16 | 2014-10-31 | 글로브이뮨 | 면역 요법으로서의 효모계 백신 |
| ES2217967B1 (es) * | 2003-03-31 | 2006-01-01 | Consejo Sup. Investig. Cientificas | Procedimiento de produccion de particulas virales vacias (vlps) del virus inductor de la bursitis infecciosa (ibdv), composiciones necesarias para su puesta a punto y su uso en la elaboracion de vacunas frente al ibdv. |
| ES2307345B1 (es) * | 2004-01-21 | 2009-11-13 | Consejo Sup. Investig. Cientificas | Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones. |
| ES2307346B1 (es) * | 2004-01-21 | 2009-11-13 | Consejo Sup. Investig. Cientificas | Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones. |
| US8420102B2 (en) * | 2006-03-07 | 2013-04-16 | Vaxinnate Corporation | Compositions that include hemagglutinin |
| ES2310062B1 (es) * | 2005-07-15 | 2009-11-13 | Bionostra, S.L. | Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones. |
| AU2007297801A1 (en) | 2006-07-14 | 2008-03-27 | Sanofi Pasteur Biologics Co. | Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins |
| EP2069483A4 (de) * | 2006-09-29 | 2010-10-27 | Sanofi Pasteur Biologics Co | Rekombinante rhinovirus-vektoren |
| CA2615372A1 (en) | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Influenza virus-like particles (vlps) comprising hemagglutinin |
| WO2009076778A1 (en) | 2007-11-27 | 2009-06-25 | Medicago Inc. | Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| AU2009236585B2 (en) | 2008-04-18 | 2013-03-07 | Vaxinnate Corporation | Deletion mutants of flagellin and methods of use |
| WO2009133463A1 (en) * | 2008-04-30 | 2009-11-05 | University Of Copenhagen | Soluble influenza vaccine |
| AU2009267769B2 (en) * | 2008-07-08 | 2015-07-16 | Medicago Inc. | Soluble recombinant influenza antigens |
| HUE039100T2 (hu) | 2009-06-24 | 2018-12-28 | Medicago Inc | Hemagglutinint tartalmazó kimer influenzavírus-jellegû részecskék |
| JP5903045B2 (ja) | 2009-07-31 | 2016-04-13 | パックスバックス， インコーポレイテッド | アデノウイルスに基づくベクター |
| KR101773431B1 (ko) | 2009-09-22 | 2017-09-12 | 메디카고 인코포레이티드 | 식물-유래 ｖｌｐ의 제조방법 |
| US10130697B2 (en) | 2010-03-23 | 2018-11-20 | Wisconsin Alumni Research Foundation (Warf) | Vaccines comprising mutant attenuated influenza viruses |
| WO2011126370A1 (en) * | 2010-04-09 | 2011-10-13 | Universiteit Utrecht Holding B.V. | Recombinant multimeric influenza proteins |
| EP2595653B1 (de) * | 2010-07-23 | 2017-06-28 | Novavax AB | Influenza-impfstoff |
| US9585953B2 (en) | 2011-03-22 | 2017-03-07 | Mucosis B.V. | Immunogenic compositions in particulate form and methods for producing the same |
| TWI620816B (zh) | 2011-03-23 | 2018-04-11 | 苜蓿股份有限公司 | 植物衍生蛋白回收方法 |
| JP2014527799A (ja) | 2011-08-26 | 2014-10-23 | ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション | 変異型ｐｂ２遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス |
| BR112015001390B1 (pt) | 2012-07-26 | 2024-04-30 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc | Proteína de fusão, ácido nucleico isolado e uso de uma composição de vacina |
| US8932598B2 (en) | 2012-08-28 | 2015-01-13 | Vaxinnate Corporation | Fusion proteins and methods of use |
| HK1208355A1 (en) * | 2012-11-05 | 2016-03-04 | Georgia State University Research Foundation, Inc. | Universal influenza vaccine based on heterologous multiple m2e proteins |
| US10053671B2 (en) | 2014-06-20 | 2018-08-21 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
| US11197925B2 (en) | 2016-02-19 | 2021-12-14 | Wisconsin Alumni Research Foundation (Warf) | Influenza B virus replication for vaccine development |
| WO2019084310A1 (en) | 2017-10-25 | 2019-05-02 | Yoshihiro Kawaoka | HAS RECOMBINANT INFLUENZA VIRUSES STABILIZED FOR EGG REPLICATION |
| KR20190065234A (ko) | 2017-11-30 | 2019-06-11 | 그리폴스 다이어그노스틱 솔루션즈 인크. | 면역 관문 억제제인 pd-1 및 pd-l1에 대한 항체 치료를 모니터링하기 위한 면역분석 및 조작된 단백질 |
| US12343390B2 (en) | 2018-08-07 | 2025-07-01 | Wisconsin Alumni Research Foundation (Warf) | Recombinant biologically contained filovirus vaccine |
| JP7655849B2 (ja) | 2018-08-20 | 2025-04-02 | ウィスコンシン アルムニ リサーチ ファンデイション | ヘマグルチニン（ｈａ）タンパク質内の非ドミナントエピトープに対する免疫応答を誘起するためのベクター |
| EP3921413A1 (de) | 2019-02-08 | 2021-12-15 | Wisconsin Alumni Research Foundation (WARF) | Humanisierte zelllinie |
| CN114929269A (zh) | 2019-05-01 | 2022-08-19 | 威斯康星校友研究基金会(Warf) | 用于疫苗开发的改进的流感病毒复制 |
| US11807872B2 (en) | 2019-08-27 | 2023-11-07 | Wisconsin Alumni Research Foundation (Warf) | Recombinant influenza viruses with stabilized HA for replication in eggs |
| JP2023511444A (ja) | 2020-01-24 | 2023-03-17 | ウィスコンシン アルムニ リサーチ ファンデイション | 安定化されたｎａを有する組換えインフルエンザウイルス |
| WO2021195410A1 (en) | 2020-03-25 | 2021-09-30 | Wisconsin Alumni Research Foundation (Warf) | Recombinant multivalent influenza viruses |
| US20240075152A1 (en) * | 2021-01-13 | 2024-03-07 | Purdue Research Foundation | Supramolecular assemblies, compositions and methods for producing and using the same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5041385A (en) | 1986-11-01 | 1991-08-20 | Oxford Gene Systems Limited | Vector expressing fusion proteins and particles |
| PT672141E (pt) * | 1992-10-23 | 2003-09-30 | Immunex Corp | Metodos de preparacao de proteinas oligomericas soluveis |
| US5721340A (en) * | 1994-11-28 | 1998-02-24 | The Wistar Institute Of Anatomy & Biology | p53 proteins with altered tetramerization domains |
| WO1999062953A1 (en) * | 1998-06-04 | 1999-12-09 | Shanghai Second Medical University | A human leucine zipper protein gene (bmh) (cblayd06) |
| MXPA01005389A (es) * | 1998-11-30 | 2003-03-27 | Cytos Biotechnology Ag | Presentacion molecular ordenada de antigenos, metodos de preparacion y uso. |
| EP1179013A1 (de) * | 1999-05-14 | 2002-02-13 | Medical Research Council | Proteingerüst und seine verwendung zur multimerisierung von monomeren peptiden |
| IL147270A0 (en) * | 1999-07-02 | 2002-08-14 | Genentech Inc | Fusion peptides comprising a peptide ligand domain and a multimerization domain |
| DE19963859A1 (de) * | 1999-12-30 | 2001-07-12 | Apotech Res & Dev Ltd | Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen |
| US20020015951A1 (en) | 2000-01-06 | 2002-02-07 | Bader Joel S. | Method of analyzing a nucleic acid |
-
2002
- 2002-01-18 CA CA2435000A patent/CA2435000C/en not_active Expired - Lifetime
- 2002-01-18 DK DK02722030T patent/DK1362109T3/da active
- 2002-01-18 AT AT02722030T patent/ATE433491T1/de active
- 2002-01-18 DE DE60232577T patent/DE60232577D1/de not_active Expired - Lifetime
- 2002-01-18 ES ES02722030T patent/ES2327719T3/es not_active Expired - Lifetime
- 2002-01-18 WO PCT/EP2002/000628 patent/WO2002074795A2/en not_active Ceased
- 2002-01-18 US US10/466,655 patent/US7449188B2/en not_active Expired - Lifetime
- 2002-01-18 AU AU2002252978A patent/AU2002252978B9/en not_active Expired
- 2002-01-18 EP EP02722030A patent/EP1362109B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002074795A3 (en) | 2003-09-04 |
| AU2002252978B9 (en) | 2007-02-01 |
| US20040116664A1 (en) | 2004-06-17 |
| AU2002252978B2 (en) | 2006-12-07 |
| ES2327719T3 (es) | 2009-11-03 |
| EP1362109B1 (de) | 2009-06-10 |
| WO2002074795A2 (en) | 2002-09-26 |
| CA2435000C (en) | 2014-03-25 |
| CA2435000A1 (en) | 2002-09-26 |
| EP1362109A2 (de) | 2003-11-19 |
| US7449188B2 (en) | 2008-11-11 |
| DK1362109T3 (da) | 2009-07-27 |
| DE60232577D1 (de) | 2009-07-23 |
| AU2002252978A1 (en) | 2002-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE433491T1 (de) | Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potential | |
| NO20000850L (no) | Vaksine | |
| DE60142689D1 (de) | Verwendung prokariotischer pest-ähnlicher peptide zur verstärkung der immunogenität von antigenen | |
| ATE320493T1 (de) | Modifizierung des hepatitis b kernantigens | |
| UY28641A1 (es) | Anticuerpos | |
| ATE317441T1 (de) | Cathepsin-02-protease | |
| CY1117551T1 (el) | Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου | |
| DE60132893D1 (de) | Antigene polypeptide | |
| NO20033673D0 (no) | Fusjonsprotein for sekresjon av et protein av interesse til supernatanten til en bakteriekultur | |
| ATE405647T1 (de) | Rekombinantes gelatin in impstoffen | |
| DE60233955D1 (de) | Spezifische bindungsmittel von human angiopoietin-2 | |
| PT759935E (pt) | L1 de virus de papiloma recombinante | |
| DK1423419T3 (da) | Hybrid- og tandemekspression af Neisseria-proteiner | |
| ATE520713T1 (de) | Identifizierung und veränderung von immundominanten polypeptidepitopen | |
| YU79491A (sh) | Varijantni cd44-površinski proteini, dna-sekvence koje ih kodiraju i antitela protiv ovih proteina | |
| ATE399180T1 (de) | Rekombinante polypeptide | |
| DE60238555D1 (de) | Parathormon-antikörper und damit zusammenhängende verfahren | |
| DK1209985T3 (da) | Modification af proteiners skumningsegenskaber | |
| ATE469655T1 (de) | Bakteriophagenvermittelte impfung | |
| ATE323763T1 (de) | Dna & protein bindende miniatur proteine | |
| DK1368372T3 (da) | Peptid med affinitet til det virale gp120-protein samt anvendelse deraf | |
| EP0652769A1 (de) | Impfstoffe gegen MetazoonParasiten. | |
| WO2002051237A3 (en) | Helicobacter proteins, nucleic acids and uses thereof | |
| DK1545594T3 (da) | Bakteriofag-medieret immunisering mod Hepatitis | |
| ATE525470T1 (de) | Antigene epitope des faktors viii, inhibitoren dagegen, und deren verwendungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1362109 Country of ref document: EP |